UNH Stock Price Today (October 2026) — UnitedHealth Group Incorporated Analysis & Key Metrics 2026-10-07
UnitedHealth Group Incorporated (UNH) is trading at $375.98, down 0.09% today (as of October 2026). The stock continues to show pressure below major moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $481.72 (28.1% upside).
- Volatility is low (14.29% annualized), implying relatively contained price movements for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: steady revenue (0.40% YoY) alongside competitive pressures in the Healthcare Plans space.
UNH Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
UnitedHealth Group Incorporated - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $379.34B
P/E Ratio
Forward P/E: 17.36
Revenue Growth
Year over Year
Analyst Target
+28.1% upside potential
Key Investor Questions About UNH
What investors need to know before buying
Based on current market data, UNH presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 48.06)
- Fundamentals say: Mixed signals (nuanced financial profile)
UNH's growth trajectory depends on its ability to expand within the Healthcare Plans sector while managing margin pressures.
- Future growth will depend on performance in core Healthcare Plans operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for UNH investors include debt exposure and competitive dynamics in the Healthcare Plans industry.
- $73.33B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Healthcare Plans.
52-Week Trading Range
Over the past year, UNH stock traded between $255.97 and $461.62 and currently trades in the middle of that range. Big swings are less likely unless a major catalyst emerges.
Volatility & Risk Profile
With 14.29% annualized volatility and β=0.42, the stock exhibits low sensitivity to market moves—making UNH suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Humana Jumps 7% on Barclays Upgrade and $515 Target; UnitedHealth Nudges Higher
Barclays just broke its silence on Humana with a conviction call that sent shares surging well past anything the broader health care sector is doing today, raising the question of whether this upgrade signals the start of something bigger or a rally built on a single opinion.
UnitedHealth, BlackRock, and Stanley Black & Decker Just Paid Shareholders. Here’s What They Got.
Three companies with nothing in common all sent dividend checks on the same September day, but only one of them handed shareholders a freshly raised rate. Which one broke from the pack, and what does each payout actually earn against the price investors paid?
Does UnitedHealth’s New CAO Hire Reveal a Deeper Shift in Efficiency Strategy for UNH?
UnitedHealth Group recently announced that Jodee Kozlak joined as chief administrative officer, a new role overseeing People, Real Estate, Procurement and Corporate Security to support enterprise modernization and alignment across the business. Kozlak’s background leading global expansion at Alibaba, human resources at Target, and board roles at C.H. Robinson Worldwide and KB Home suggests UnitedHealth is placing greater emphasis on organizational efficiency and large-scale transformation...
Q2 Earnings Outperformers: UnitedHealth (NYSE:UNH) And The Rest Of The Health Insurance Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how UnitedHealth (NYSE:UNH) and the rest of the health insurance providers stocks fared in Q2.
UnitedHealth names first chief administrative officer
Jodee Kozlak, a veteran of major multinational corporations, will join UnitedHealth this coming Monday to modernize and align the healthcare behemoth’s operations across its various businesses.
UnitedHealth: Inside the $942 Million Industry Problem Squeezing Its Margins
Key TakeawaysUnitedHealth’s commercial segment cost trend ran modestly above 11% in the first half of 2026, with roughly 100 basis points tied to arbitration abuse and provider coding intensity, the same billing dynamic a new Blue Cross Blue Shield Association study says cost insurers $942 million industry wide over two years. Management pushed commercial margin recovery past 2027, a full year later than planned, even as the consolidated medical care ratio improved to 86.
UnitedHealth Group (UNH) Stock Trades At A Discount Despite A 21% Slide
UnitedHealth Group has seen its share price deliver mixed results in recent years, with shorter term gains sitting alongside a longer multi year decline. That uneven share price path puts the spotlight on a simple question for investors who follow UnitedHealth Group stock: whether the current valuation is backed up by its earnings power. Over the past 3 years the stock has declined 21.4%, which puts more weight on whether the earnings profile justifies where the shares trade today. Recent...
UnitedHealth Group (UNH) Stock Moves -1.26%: What You Should Know
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $372.8, denoting a -1.26% move from the preceding trading day.
Can UNH Stock Keep Growing Earnings While Its Sales Stall?
UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.
Should You Buy UnitedHealth Group Stock Before Oct. 13?
The healthcare giant reports earnings next month.
Explore More Analysis for UNH
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 13, 2026 (before the open)
Frequently Asked Questions
Common investor questions about UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) is currently trading at $375.98. The RSI (14-day) is at 48.1, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $481.72 implies 28.1% upside from current levels. Volatility is low at 14.3% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for UnitedHealth Group Incorporated (UNH): The trailing P/E ratio is 24.87, which is in line with broader market averages. The forward P/E is 17.36, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.22, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.53. Price-to-Sales is 0.76. Valuation should be compared to Healthcare Plans industry peers for context, as different sectors trade at different multiples.
Based on 25 analysts covering UNH, the consensus price target is $481.72. This represents a 28.1% upside from the current price of $375.98. The range spans from a low target of $380.00 to a high target of $529.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a current yield of approximately 2.47%. The annualized dividend rate is $8.95 per share. The payout ratio is 57.5%, which is moderate and suggests adequate earnings coverage for the dividend. The most recent ex-dividend date was Sep 14, 2026.
Key risks for UnitedHealth Group Incorporated (UNH) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Healthcare Plans sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is UnitedHealth Group Incorporated's (UNH) current debt and financial health profile: Total debt stands at $73.33B. The debt-to-equity ratio is 0.69x, which is moderate and generally manageable for most companies. The current ratio is 0.78, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.70. The company holds $31.47B in cash and equivalents. Free cash flow is positive at $24.27B, providing a cushion for debt servicing and shareholder returns.